Total planned funding: $368,404,108
Clear active filters
University
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Mozambique | $91,100,541 |
| Kenya | $55,233,402 |
| Tanzania | $49,009,820 |
| Zambia | $29,601,379 |
| South Africa | $16,892,295 |
| Ethiopia | $15,717,486 |
| Botswana | $13,088,221 |
| Namibia | $12,826,600 |
| Côte d'Ivoire | $11,961,581 |
| Malawi | $10,840,623 |
| Democratic Republic of the Congo | $9,988,957 |
| Nigeria | $7,236,178 |
| Eswatini | $6,074,865 |
| Lesotho | $5,142,197 |
| Uganda | $4,583,637 |
| South Sudan | $3,792,945 |
| Caribbean Region | $3,757,200 |
| Angola | $3,598,636 |
| Central Asia Region | $3,163,000 |
| Central America Region | $2,903,298 |
| Rwanda | $2,450,750 |
| Haiti | $2,425,500 |
| Vietnam | $1,791,997 |
| Ukraine | $1,600,000 |
| Burma | $1,300,000 |
| Zimbabwe | $973,000 |
| Burundi | $600,000 |
| India | $600,000 |
| Ghana | $150,000 |
Organizational Types
| University | $368,404,108 |
Program Areas
| Treatment | $145,229,319 |
| Prevention | $79,205,880 |
| Governance and Systems | $49,563,014 |
| Care | $48,190,889 |
| Testing | $46,215,006 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $132,582,812 |
| HVCT: Testing: HIV Testing and Counseling | $46,215,006 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $31,371,191 |
| HVSI: Strategic Information | $29,915,061 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $27,505,410 |
| HBHC: Care: Adult Care and Support | $20,498,702 |
| OHSS: Health Systems Strengthening | $14,158,121 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $13,566,929 |
| PDTX: Treatment: Pediatric Treatment | $12,646,507 |
| HKID: Care: Orphans and Vulnerable Children | $11,020,111 |
| HVTB: Care: TB/HIV | $10,088,943 |
| PDCS: Care: Pediatric Care and Support | $6,583,133 |
| HLAB: Laboratory Infrastructure | $5,489,832 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $4,029,512 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $1,656,956 |
| HMBL: Biomedical Prevention: Blood Safety | $633,250 |
| HMIN: Biomedical Prevention: Injection Safety | $442,632 |